Full-Time

Junior Business Analyst

STEM Healthcare

STEM Healthcare

501-1,000 employees

Data-driven advisory optimizing life-science commercialization

No salary listed

London, UK

Hybrid

Hybrid role; remote and London office (Holborn gate).

Bachelor's

Category
Business & Strategy (1)
Required Skills
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to STEM Healthcare

See people who can refer or advise you

Requirements
  • Full proficiency in English and Japanese is required.
  • A Science-based degree with numerical emphasis (such as Chemistry, Physics, Mathematics, Engineering) or experience as an Analyst is required.
  • Strong communication and project management skills to handle multiple projects with different stakeholders.
  • Experience in using Microsoft Excel and Microsoft PowerPoint.
  • Proactive with drive and ambition and a strong work ethic to grow in a dynamic environment with opportunities to help develop and further the business as a whole.
  • Analytical thinking.
  • Problem-solving.
Responsibilities
  • Liaising with internal STEM senior leadership and local project teams to establish project delivery requirements.
  • Client facing relationship building through project set up and delivery as well as managing external requests and deadlines.
  • Managing multiple client projects.
  • Building and maintaining Microsoft Excel databases from source data.
  • Analyzing client data using quantitative and qualitative methods to evaluate key performance indicators.
  • Pressure testing source data and identifying areas for investigation.
  • Collaborating with project leaders and local teams to interpret data and formulate action plans and recommendations for clients.
  • Producing high quality presentations and other deliverables for clients using Microsoft PowerPoint.
  • Supporting members of the analysis team to meet client deadlines and drive development and efficiencies within the team.

STEM Healthcare provides advisory services to pharmaceutical and life science companies to improve commercial performance by measuring how well brand strategies are executed in the real world. The company uses a specific methodology and benchmarking data to analyze a product's progress at every stage, from early development to the end of its market life. Unlike competitors that may focus on isolated stages, STEM offers a connected approach through the Inizio Advisory network to simplify complex commercialization challenges. Its goal is to help clients increase their return on investment and ensure that important medicines successfully reach the patients who need them.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$110.9M

Headquarters

York, Pennsylvania

Founded

2007

Get referred to STEM Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • STEM AI expands STEM from audits into ongoing workflow software and coaching.
  • Inizio Ignite gives STEM cross-sell access to 1,000+ experts and 1,100 assets.
  • Dermot Kenny, CEO since November 2021, now steers geographic expansion and product diversification.

What critics are saying

  • STEM depends on 29 of the top 30 pharma companies, concentrating revenue risk.
  • AI benchmarking tools commoditize fast, pressuring STEM's premium advisory pricing by 2026.
  • Inizio Ignite integration can dilute STEM's brand; client teams can buy unified competitors instead.

What makes STEM Healthcare unique

  • STEM paired observational audits with a proprietary pharma performance benchmark database since 2007.
  • Inizio Ignite folded STEM into a larger advisory platform on January 6, 2026.
  • STEM AI launched September 24, 2025, using field-call recordings for personalized coaching.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Professional Development Budget

Company News

PharmaVoice
Dec 15th, 2021
STEM Marketing hires Dermot Kenny as CEO

All you have to do is check your mail and you will be directed back to PharmaVOICE.com Leading global pharmaceutical and life sciences auditing firm, STEM Healthcare, part of Ashfield Advisory, has appointed Dermot Kenny as its new CEO.